Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

242.56USD
4:02pm EDT
Change (% chg)

$0.79 (+0.33%)
Prev Close
$241.77
Open
$243.27
Day's High
$243.27
Day's Low
$240.39
Volume
88,223
Avg. Vol
67,033
52-wk High
$243.27
52-wk Low
$136.64

Chart for

About

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments:... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $10,888.70
Shares Outstanding(Mil.): 45.04
Dividend: 0.34
Yield (%): 0.56

Financials

  Industry Sector
P/E (TTM): -- 31.44 16.08
EPS (TTM): -- -- --
ROI: -- 13.78 14.60
ROE: -- 16.62 14.03

Device maker Teleflex boosts urology business with NeoTract buy

Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices.

Sep 05 2017

UPDATE 3-Device maker Teleflex boosts urology business with NeoTract buy

* Teleflex sees mid-single digits sales bump going forward (Adds conference call details, analyst comment, shares)

Sep 05 2017

BRIEF-Teleflex Inc to acquire NeoTract for up to $1.1 bln​

* Teleflex Inc - ‍Teleflex will acquire NeoTract in a transaction valued up to $1.1 billion​

Sep 05 2017

Medical tech provider Teleflex to buy NeoTract in $1.1 bln deal

Sept 5 Medical technologies provider Teleflex Inc said on Tuesday it would buy privately-held NeoTract Inc in a deal valued at up to $1.1 billion.

Sep 05 2017

BRIEF-Teleflex awarded group purchasing contract with Vizient for central venous catheters

* Teleflex awarded group purchasing contract with Vizient Inc for non-tunneled central venous catheters

Aug 23 2017

BRIEF-Arrow Seldinger Arterial Catheterization Device receives FDA market clearance - Teleflex Inc

* Teleflex Inc says that its Arrow Seldinger Arterial Catheterization Device received market clearance from U.S. Food And Drug Administration

Jul 24 2017

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma

May 15 2017

BRIEF-Teleflex receives FDA 510(k) clearance for Arrow AC3 Optimustm Intra-Aortic Balloon Pump

* Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp)

May 02 2017

BRIEF-Pyng receives securityholder approval for acquisition by Teleflex

* Pyng receives securityholder approval for acquisition by Teleflex Source text for Eikon: Further company coverage:

Mar 27 2017

Competitors

  Price Chg
C R Bard Inc (BCR.N) $318.50 -0.13
Medtronic PLC (MDT.N) $78.27 -1.43
Becton Dickinson and Co (BDX.N) $193.20 +0.14

Earnings vs. Estimates